Results 21 to 30 of about 2,290 (178)

Prognostic feature based on androgen-responsive genes in bladder cancer and screening for potential targeted drugs [PDF]

BioData Mining
Objectives Bladder cancer (BLCA) is a tumor that affects men more than women. The biological function and prognostic value of androgen-responsive genes (ARGs) in BLCA are currently unknown.
Jiang Zhao, Qian Zhang, Cunle Zhu, Wu Yuqi, Guohui Zhang, Qianliang Wang, Xingyou Dong, Benyi Li, Xiangwei Wang   +8 more
doaj   +2 more sources

Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis

Drug Design, Development and Therapy, 2021
Hui Zhang,1 Minghui Li,1 Jing Zhang,1 Yanbing Shen,2 Qi Gui2 1College of Medical, Huanghuai University, Zhumadian, Henan, People’s Republic of China; 2Department of Urology, The Central Hospital of Zhumadian, Zhumadian, Henan, People’s ...
Zhang H, Li M, Zhang J, Shen Y, Gui Q
doaj   +4 more sources

Proteomic Profiling of Pre- and Post-Surgery Saliva of Glioblastoma Patients: A Pilot Investigation. [PDF]

Int J Mol Sci
Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor characterized by a high infiltration capability and recurrence rate. Early diagnosis is crucial to improve the prognosis and to personalize the therapeutic approach.
Muntiu A, Moresi F, Vincenzoni F, Rossetti DV, Iavarone F, Messana I, Castagnola M, La Rocca G, Mazzucchi E, Olivi A, Urbani A, Sabatino G, Desiderio C.   +12 more
europepmc   +3 more sources

TPD52 as a Therapeutic Target Identified by Machine Learning Shapes the Immune Microenvironment in Breast Cancer. [PDF]

J Cell Mol Med
ABSTRACT Breast cancer (BRCA) is one of the most common malignancies and a leading cause of cancer‐related mortality among women globally. Despite advances in diagnosis and treatment, the heterogeneity of BRCA presents significant challenges for effective management and prognosis.
Xia J, Zhou X.
europepmc   +2 more sources

Androgen receptor suppresses lung cancer invasion and increases cisplatin response via decreasing TPD52 expression. [PDF]

Int J Biol Sci, 2023
Lung cancer, as the most commonly diagnosed malignancy, still accounts for the leading cause of cancer-related deaths worldwide. The high rate of mortality and tumor recurrence has prompted clinicians and scientists to urgently explore new targets for improved treatment.
Liu S, Hu C, Li M, Zhou W, Wang R, Xiao Y.   +5 more
europepmc   +3 more sources

MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52 [PDF]

Journal of Healthcare Engineering, 2022
Background. Many researchers have confirmed that miRNAs are involved in the pathogenesis of gastric cancer (GC). This study focused on investigating the specific functions of miR-139-5p in GC. Methods. MiR-139-5p and TPD52 expressions were observed by qRT-PCR or western blot in GC.
Yuanbo Li, Yan Sun, Zhenlu Li, Shikuan Li, Changliang Wu   +4 more
openaire   +2 more sources

Retracted: MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52. [PDF]

J Healthc Eng, 2023
Engineering JOH.
europepmc   +2 more sources

Tumor protein D52 is upregulated in oral squamous carcinoma cells under hypoxia in a hypoxia-inducible-factor-independent manner and is involved in cell death resistance

Cell & Bioscience, 2021
Background Tumor protein D52 (TPD52) reportedly plays an important role in the proliferation and metastasis of various cancer cells, including oral squamous cell carcinoma (OSCC) cells, and is expressed strongly at the center of the tumor, where the ...
Yuzo Abe, Yoshiki Mukudai, Mai Kurihara, Asami Houri, Junichiro Chikuda, Atsutoshi Yaso, Kosuke Kato, Toshikazu Shimane, Tatsuo Shirota   +8 more
doaj   +1 more source

MicroRNA-224 Targets SMAD Family Member 4 to Promote Cell Proliferation and Negatively Influence Patient Survival [PDF]

, 2013
10.1371/journal.pone.0068744PLoS ONE87 ...
A Alibes, A Brunet Vega, Alexander Y. F. Chung, C Scisciani, Caroline G. L. Lee, Dong-Yan Jin, F Xiao, G Giannelli, G Yang, G Yao, GM Arndt, Han Chong Toh, J Boguslawska, Jianwei Ren, Joel Z. I. Ma, L Huang, London L. P. J. Ooi, M Miyaki, NM Meindl-Beinker, Pierce Chow, Q Li, SD Selcuklu, SN Shen, W Huang da, W Huang da, X Li, Y Tang, Y Wang, Y Wang, Y Wang, Y Wang, Y Wang, Yu Wang, Yun Gao, YX Wang   +34 more
core   +15 more sources

TPD52 (tumor protein D52) [PDF]

Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on TPD52 (tumor protein D52), with data on DNA, on the protein encoded, and where the gene is implicated.
Della-Franca, A, Byrne, J
openaire   +2 more sources